相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs
Zhenke Wen et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease
Tsuyoshi Shirai et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Differential control of CD4+ T-cell subsets by the PD-1/PD-L1 axis in a mouse model of allergic asthma
Jaclyn W. McAlees et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
Eoin F. McKinney et al.
NATURE (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis
Francesco Ciccia et al.
RHEUMATOLOGY (2015)
TGF-β Signaling Mediates Endothelial-to-Mesenchymal Transition (EndMT) During Vein Graft Remodeling
Brian C. Cooley et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Drug-associated polymyalgia rheumatica/giant cell arteritis occurring in two patients after treatment with ipilimumab, an antagonist of CTLA-4
Barbara L. Goldstein et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Immune mechanisms in medium and large-vessel vasculitis
Cornelia M. Weyand et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma
Omid Hamid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis
Benjamin Terrier et al.
ARTHRITIS AND RHEUMATISM (2012)
Pericyte Depletion Results in Hypoxia-Associated Epithelial-to-Mesenchymal Transition and Metastasis Mediated by Met Signaling Pathway
Vesselina G. Cooke et al.
CANCER CELL (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Aberrant expression of the negative costimulator PD-1 on T cells in granulomatosis with polyangiitis
Benjamin Wilde et al.
RHEUMATOLOGY (2012)
Participation of blood vessel cells in human adaptive immune responses
Jordan S. Pober et al.
TRENDS IN IMMUNOLOGY (2012)
Regulation and function of mTOR signalling in T cell fate decisions
Hongbo Chi
NATURE REVIEWS IMMUNOLOGY (2012)
Combining immunotherapy and targeted therapies in cancer treatment
Matthew Vanneman et al.
NATURE REVIEWS CANCER (2012)
Blocking the NOTCH Pathway Inhibits Vascular Inflammation in Large-Vessel Vasculitis
Kisha Piggott et al.
CIRCULATION (2011)
IFN-gamma and IL-17: the two faces of T-cell pathology in giant cell arteritis
Cornelia M. Weyand et al.
CURRENT OPINION IN RHEUMATOLOGY (2011)
Th17 and Th1 T-Cell Responses in Giant Cell Arteritis
Jiusheng Deng et al.
CIRCULATION (2010)
The PD-1 pathway in tolerance and autoimmunity
Loise M. Francisco et al.
IMMUNOLOGICAL REVIEWS (2010)
The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Greg M. Delgoffe et al.
IMMUNITY (2009)
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Loise M. Francisco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Vessel-specific Toll-like receptor profiles in human medium and large arteries
Olga Pryshchep et al.
CIRCULATION (2008)
Activation drives PD-1 expression during vaccine-specific proliferation and following lentiviral infection in macaques
David A. Hokey et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways
Brian T. Fife et al.
IMMUNOLOGICAL REVIEWS (2008)
The Common γ-Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Induce the Expression of Programmed Death-1 and Its Ligands
Audrey L. Kinter et al.
JOURNAL OF IMMUNOLOGY (2008)
Is intimal hyperplasia a marker of neuro-ophthalmic complications of giant cell arteritis?
D. Makkuni et al.
RHEUMATOLOGY (2008)
Imatinib mesylate inhibits in vitro and ex vivo biological responses related to vascular occlusion in giant cell arteritis
E. Lozano et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Biopsy-negative giant cell arteritis: Does anti-CD83 immunohistochemistry advance the diagnosis?
Gleb Slobodin et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2007)
PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -γ and mediates T cell apoptosis
Marcus Muehlbauer et al.
JOURNAL OF HEPATOLOGY (2006)
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Cheryl L. Day et al.
NATURE (2006)
Tissue expression of PD-L1 mediates peripheral T cell tolerance
ME Keir et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber et al.
NATURE (2006)
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
RV Parry et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand
S Hirata et al.
JOURNAL OF IMMUNOLOGY (2005)
Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity
LP Chen
NATURE REVIEWS IMMUNOLOGY (2004)
B7-H1 determines accumulation and deletion of intrahepatic CD8+ T lymphocytes
HD Dong et al.
IMMUNITY (2004)
Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis
W Ma-Krupa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells
YE Latchman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation:: relevance for the immune modulatory effect in multiple sclerosis
B Schreiner et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Mechanisms of disease: Medium- and large-vessel vasculitis
CM Weyand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Blockade of programmed death-1 Ligands on dendritic cells enhances T cell activation and cytokine production
JA Brown et al.
JOURNAL OF IMMUNOLOGY (2003)
B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis
MM Mazanet et al.
JOURNAL OF IMMUNOLOGY (2002)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine
T Okazaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
PD-1: an inhibitory immunoreceptor involved in peripheral tolerance
H Nishimura et al.
TRENDS IN IMMUNOLOGY (2001)
Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice
H Nishimura et al.
SCIENCE (2001)
IFN-gamma action in the media of the great elastic arteries, a novel immunoprivileged site
AJ Dal Canto et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
